Innovascreen's proprietary platforms accelerate pre-clinical development through two proprietary platforms, the ASET Platform for early preclinical research and the Fusogenix Platform for drug delivery, Innovascreen has the tools to accelerate an important stage of the development process. Whether combined with internal programs or partnered with external compounds, these platforms have the opportunity to add significant value to preclinical therapeutic opportunities.